Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2015-02-23 (11 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PLOUDALMEZEAU (29830), Finistere
SELARL PHARMACIE ROUDAUT-LE GALL : revenue, balance sheet and financial ratios
SELARL PHARMACIE ROUDAUT-LE GALL is a French company
founded 11 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PLOUDALMEZEAU (29830),
this company of category PME
shows in 2023 a revenue of 2.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE ROUDAUT-LE GALL (SIREN 811229772)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
2 164 928 €
N/C
N/C
N/C
N/C
1 549 553 €
1 427 773 €
Net income
115 568 €
151 675 €
115 955 €
87 112 €
113 402 €
108 326 €
99 589 €
97 501 €
99 946 €
EBITDA
N/C
N/C
177 273 €
N/C
N/C
N/C
N/C
170 608 €
168 153 €
Net margin
N/C
N/C
5.4%
N/C
N/C
N/C
N/C
6.3%
7.0%
Revenue and income statement
In 2025, SELARL PHARMACIE ROUDAUT-LE GALL generates positive net income of 116 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 100 k€ -> 116 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
115 568 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 31%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 64%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
30.829%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
64.357%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE ROUDAUT-LE GALL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
859.96
445.2
271.395
182.578
127.39
106.528
78.488
49.62
30.829
Financial autonomy
9.571
16.738
24.912
31.011
38.489
41.779
46.813
57.59
64.357
Repayment capacity
9.453
8.574
None
None
None
None
4.419
None
None
Cash flow / Revenue
8.569%
7.773%
None%
None%
None%
None%
6.058%
None%
None%
Sector positioning
Debt ratio
30.832025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good-16 pts over 3 years
In 2025, the debt ratio of SELARL PHARMACIE ROUDAUT-... (30.83) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
64.36%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good+17 pts over 3 years
In 2025, the financial autonomy of SELARL PHARMACIE ROUDAUT-... (64.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
4.42 years2023
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Average
In 2023, the repayment capacity of SELARL PHARMACIE ROUDAUT-... (4.42) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 197.42. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
197.417
Liquidity indicators evolution SELARL PHARMACIE ROUDAUT-LE GALL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
201.717
192.2
197.207
175.03
184.147
206.515
172.162
204.912
197.417
Interest coverage
10.293
9.17
None
None
None
None
4.531
None
None
Sector positioning
Liquidity ratio
197.422025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Good+13 pts over 3 years
In 2025, the liquidity ratio of SELARL PHARMACIE ROUDAUT-... (197.42) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
4.53x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Good
In 2023, the interest coverage of SELARL PHARMACIE ROUDAUT-... (4.5x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE ROUDAUT-LE GALL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
75 529 €
70 350 €
0 €
0 €
0 €
0 €
47 109 €
0 €
0 €
Inventory turnover (days)
26
21
0
0
0
0
16
0
0
Customer payment term (days)
4
3
0
0
0
0
4
0
0
Supplier payment term (days)
20
25
0
0
0
0
30
0
0
Positioning of SELARL PHARMACIE ROUDAUT-LE GALL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELARL PHARMACIE ROUDAUT-LE GALL is estimated at
1 835 811 €
(range 1 245 790€ - 2 880 640€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1245k€1835k€2880k€
1 835 811 €Range: 1 245 790€ - 2 880 640€
NAF 5 année 2025
Valuation method used
Net Income Multiple
115 568 €
×
15.9x
=1 835 811 €
Range: 1 245 790€ - 2 880 641€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE ROUDAUT-LE GALL with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE ROUDAUT-LE GALL
What is the revenue of SELARL PHARMACIE ROUDAUT-LE GALL ?
The revenue of SELARL PHARMACIE ROUDAUT-LE GALL in 2023 is 2.2 M€.
Is SELARL PHARMACIE ROUDAUT-LE GALL profitable?
Yes, SELARL PHARMACIE ROUDAUT-LE GALL generated a net profit of 116 k€ in 2025.
Where is the headquarters of SELARL PHARMACIE ROUDAUT-LE GALL ?
The headquarters of SELARL PHARMACIE ROUDAUT-LE GALL is located in PLOUDALMEZEAU (29830), in the department Finistere.
Where to find the tax return of SELARL PHARMACIE ROUDAUT-LE GALL ?
The tax return of SELARL PHARMACIE ROUDAUT-LE GALL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE ROUDAUT-LE GALL operate?
SELARL PHARMACIE ROUDAUT-LE GALL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart